Approval · Notice of Compliance 10495 · 2009
MULTAQ: Notice of Compliance 10495
Issued August 11, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10495
- Date
- August 11, 2009
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Antiarrhythmic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MULTAQ | 02330989 | Marketed |
Medicinal ingredients
- DRONEDARONE HYDROCHLORIDE 400 MG per TAB